Verde Science Current Assets
The Current Assets of Verde Science (VRCI) as of Jul 23, 2026 is 100.00 USD. In the previous year, Current Assets was 200.00 USD — a change of -50.00% (lower).
Get this data via API
Financial Data API
Current Assets
100.00USD
YoY
-50.00%
Last updated:
Current Assets of Verde Science is 2026 100.00 USD. Current Assets of Verde Science was 2025 200.00 USD. It decreases by -50.00% lower compared to the previous year.
Access this data via the Eulerpool API
Verde Science Stock analysis
What does Verde Science do? Verde Science Inc is an American company specializing in the development of cannabis products for medical use. It was founded in 2014 by Dr. Mike Dorsey and is headquartered in Fayetteville, Arkansas.
The idea for starting the company arose when Dr. Dorsey treated many patients with serious illnesses that conventional medications were not sufficient for. He recognized the potential of cannabis as an alternative and decided to start a company specializing in the development of high-quality cannabis products for medical use.
Verde Science's business model is based on the production of cannabinoid-based medications for patients with various health problems. The company employs an integrated value chain that allows it to handle the entire production and processing process in-house, from planning and research to manufacturing and marketing.
The company has established different divisions to expand its activities into various areas of the market. One of the main divisions is research and development, where the company constantly works on new products and technologies to better tap into the potential of cannabis as medicine.
The second division is the production of cannabinoid-based medications that can be used to treat various diseases. The company manufactures various products, including oils, creams, capsules, and tinctures, with each product tailored to the specific needs of the patient.
Another division is the distribution of the products. The company specializes in online sales and operates its own online shop, delivering products directly to customers. Additionally, the company collaborates with various distribution partners to distribute its products through pharmacies, specialized doctors, and health centers.
Verde Science is known for its high-quality products made from natural and organically grown raw materials. The products are free from pesticides and other chemicals and undergo testing in modern laboratories to ensure optimal quality and effectiveness.
Another focus of Verde Science is educating patients and medical professionals about the use of cannabinoids as medicine. The company offers training and seminars to increase awareness of the benefits of cannabis as an alternative to conventional medications.
In summary, Verde Science Inc offers high-quality cannabinoid-based medications for various health problems. The company specializes in research, development, production, and distribution of high-quality cannabis products. The raw materials used in the products are organic and free from pesticides and other chemicals. Verde Science has also focused on educating and training patients and medical personnel to promote the use of cannabinoids as medicine. Verde Science is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Verde Science stock
Current Assets of Verde Science is 100.00 USD in 2026.
Access this data via the Eulerpool API
Balance Sheet — Verde Science
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — Verde Science
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth